Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new document revision tag v3.6.3 has been added, and the previous v3.6.2 tag was removed, indicating an updated set of study materials without changing the underlying study details.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous Revision: v3.6.0. This reflects a small platform update with no visible changes to the study information.SummaryDifference0.1%

- Check22 days agoChange DetectedNo text changes are listed for the page. The current content is unchanged according to the input data.SummaryDifference0.1%

- Check30 days agoChange DetectedRecruitment status was updated to indicate that no new participants are being enrolled, clarifying the study's current accessibility. Navigation and labeling changes were made, including adding links such as How to Read a Study Record, Common Questions, How to Join a Study, and standardizing the Intervention/Treatment label, along with a revision version change from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor, non-user-facing update to the site.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3. This indicates a new version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.